Latest Utilities News

Bannerman Energy reports solid progress on its Etango Uranium Project with construction milestones met, a robust cash position, and a bullish uranium market backdrop.

Acusensus has secured major contract expansions across Australia and New Zealand, driving a 15.8% revenue increase in Q2 FY25 and bolstering its cash reserves to $30.3 million. The company’s strategic international push and innovative enforcement technologies position it for sustained growth.

Enterprise Metals Limited has secured a heritage agreement and government grant to progress drilling at its Doolgunna Project, while also navigating key board appointments and capital raises in the December 2024 quarter.

Energy Action Limited reported a positive net cash inflow from operating activities of $1.076 million for the December quarter, maintaining a solid cash position amid ongoing financing arrangements.

Altech Batteries Limited has made significant strides in funding and technology for its CERENERGY® battery project, including a $4 million capital raise and a breakthrough 55% increase in lithium-ion battery anode energy density.

Quantum Graphite has lodged its final US$300 million financing application with the US EXIM Bank for Project Utile, alongside securing a new exploration license EL7019 in South Australia. The company is poised to release updated JORC 2012 exploration targets soon, underpinning its growth strategy.

Boss Energy has declared commercial production effective January 1, 2025, reporting strong quarterly uranium output growth and a robust financial position. The company remains on track to deliver 850,000 pounds of U3O8 in FY2025 amid ongoing ramp-up and expansion initiatives.

Anax Metals has confirmed the success of its scaled-up bioleaching technology, achieving copper recoveries of up to 80% and zinc recoveries exceeding 90%, reinforcing its strategic position in Pilbara's base metals sector.

Microba Life Sciences reports a remarkable 102% revenue increase in Q2 FY25, driven by strong sales of its MetaXplore test in Australia and promising early traction in the UK. The company also advances its therapeutic pipeline with key clinical milestones.

Universal Biosensors is expanding its handheld testing portfolio with the upcoming AQUASCOUT water sensor and growing sales of its FDA-approved Xprecia Prime blood coagulation device, targeting multi-billion-dollar markets.

Experience Co Limited reports robust Q2 2025 earnings growth, driven by strong revenue gains in skydiving and adventure experiences despite ongoing macroeconomic challenges. The company highlights operational efficiencies and positive cash flow amid a gradual inbound tourism recovery.

4DMedical reports a remarkable 202% increase in Q2 FY2025 operating revenue, driven by rapid site expansion and key collaborations with leading healthcare providers and the U.S. Department of Defense.